These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23558944)

  • 1. The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.
    You F; Hu J; Li X; Li Y
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1453-62. PubMed ID: 23558944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturable sinusoidal uptake is rate-determining process in hepatic elimination of docetaxel in rats.
    Yoon I; Han S; Choi YH; Kang HE; Cho HJ; Kim JS; Shim CK; Chung SJ; Chong S; Kim DD
    Xenobiotica; 2012 Nov; 42(11):1110-9. PubMed ID: 22747239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugate (MTC-220) of muramyl dipeptide analogue and paclitaxel prevents both tumor growth and metastasis in mice.
    Ma Y; Zhao N; Liu G
    J Med Chem; 2011 Apr; 54(8):2767-77. PubMed ID: 21405130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL.
    Ellis AG; Webster LK
    Cancer Chemother Pharmacol; 1999; 43(1):13-8. PubMed ID: 9923536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure.
    Zamek-Gliszczynski MJ; Abraham TL; Alberts JJ; Kulanthaivel P; Jackson KA; Chow KH; McCann DJ; Hu H; Anderson S; Furr NA; Barbuch RJ; Cassidy KC
    Drug Metab Dispos; 2013 Apr; 41(4):714-26. PubMed ID: 23305709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters.
    Meng Q; Liu Q; Wang C; Sun H; Kaku T; Kato Y; Liu K
    Drug Metab Pharmacokinet; 2010; 25(4):320-7. PubMed ID: 20814152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cysteine on the pharmacokinetics of paclitaxel in rats.
    Lee YK; Han SY; Chin YW; Choi YH
    Arch Pharm Res; 2012 Mar; 35(3):509-16. PubMed ID: 22477198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biliary excretion of mitoxantrone in rats.
    Yang X; Morris ME
    J Pharm Sci; 2010 May; 99(5):2502-10. PubMed ID: 20013854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
    Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
    Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
    Lee JH; Lee A; Oh JH; Lee YJ
    Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.
    Jemnitz K; Veres Z; Tugyi R; Vereczkey L
    Toxicol In Vitro; 2010 Mar; 24(2):605-10. PubMed ID: 19853032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic stability of 2'-ethylcarbonate-linked paclitaxel in serum and conversion to paclitaxel by rabbit liver carboxylesterase for use in prodrug/enzyme therapy.
    Tanino T; Nawa A; Miki Y; Iwaki M
    Biopharm Drug Dispos; 2008 Jul; 29(5):259-69. PubMed ID: 18496885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.